Cellular and biochemical response to chaperone versus substrate reduction therapies in neuropathic Gaucher disease

Margarita M. Ivanova(University of Louisville), Özlem Göker-Alpan(Lysosomal and Rare Disorders Research and Treatment Center)
bioRxiv (Cold Spring Harbor Laboratory)
February 4, 2021
Cited by 7


Related Papers